Loftus Michael J, Everts Richard J, Cheng Allen C, Eti Perenise, Fakasiieiki Timote, Isaia Lupeoletalelei, Isopo Enita, Jenney Adam W J, Lameko Viali, Leaupepe Hinauri, Leavai Folototo, Lee Sue J, Moungaevalu Mele, Stewardson Andrew J, Tekoaua Rosemary, Tou Douglas, Wuatai Geoffrey, Peleg Anton Y
Department of Infectious Diseases, The Alfred Hospital and Central Clinical School, Monash University, Melbourne, Australia.
Nelson Bays Primary Health, Nelson, New Zealand.
Lancet Reg Health West Pac. 2023 Feb 2;32:100677. doi: 10.1016/j.lanwpc.2022.100677. eCollection 2023 Mar.
There are limited antimicrobial resistance (AMR) surveillance data from low- and middle-income countries, especially from the Pacific Islands region. AMR surveillance data is essential to inform strategies for AMR pathogen control.
We performed a retrospective analysis of antimicrobial susceptibility results from the national microbiology laboratories of four Pacific Island countries - the Cook Islands, Kiribati, Samoa and Tonga - between 2017 and 2021. We focused on four bacteria that have been identified as 'Priority Pathogens' by the World Health Organization: and
Following deduplication, a total of 20,902 bacterial isolates was included in the analysis. The most common organism was (n = 8455) followed by (n = 7830), (n = 2689) and (n = 1928). The prevalence of methicillin resistance among isolates varied between countries, ranging from 8% to 26% in the Cook Islands and Kiribati, to 43% in both Samoa and Tonga. Ceftriaxone susceptibility remained high to moderate among (87%-94%) and (72%-90%), whereas amoxicillin + clavulanate susceptibility was low against these two organisms (50%-54% and 43%-61%, respectively). High susceptibility was observed for all anti-pseudomonal agents (83%-99%).
Despite challenges, these Pacific Island laboratories were able to conduct AMR surveillance. These data provide valuable contemporary estimates of AMR prevalence, which will inform local antibiotic formularies, treatment guidelines, and national priorities for AMR policy.
Supported by the National Health and Medical Research Council.
低收入和中等收入国家,尤其是太平洋岛屿地区的抗菌药物耐药性(AMR)监测数据有限。AMR监测数据对于制定AMR病原体控制策略至关重要。
我们对2017年至2021年间四个太平洋岛国——库克群岛、基里巴斯、萨摩亚和汤加——国家微生物实验室的抗菌药物敏感性结果进行了回顾性分析。我们重点关注了世界卫生组织确定为“优先病原体”的四种细菌: 和
经过去重后,分析共纳入了20902株细菌分离株。最常见的病原体是 (n = 8455),其次是 (n = 7830)、 (n = 2689)和 (n = 1928)。各国 分离株中耐甲氧西林的流行率有所不同,在库克群岛和基里巴斯为8%至26%不等,在萨摩亚和汤加均为43%。头孢曲松对 (87%-94%)和 (72%-90%)的敏感性仍然较高至中等,而阿莫西林+克拉维酸对这两种病原体的敏感性较低(分别为50%-54%和43%-61%)。所有抗假单胞菌药物的敏感性都很高(83%-99%)。
尽管面临挑战,但这些太平洋岛屿实验室仍能够开展AMR监测。这些数据提供了AMR流行率的宝贵当代估计值,将为当地抗生素处方集、治疗指南以及AMR政策的国家优先事项提供参考。
由国家卫生与医学研究委员会提供支持。